Search results
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 24 hours agoThe majority of the large drugmakers...over year. Here we discuss five drug/generic companies,...
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
Motley Fool via Yahoo Finance· 16 hours agoIn terms of debits from the profit and loss statement, the pharmaceutical company managed to shave...
NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data
Morningstar· 21 hours agoPharmaceuticals shares were up 38% to $2.90 after the company said it saw a statistically significant safety advantage of NRX-101 compared to the standard ...
Mirum reports positive results from LIVMARLI study in PFIC patients By Investing.com
Investing.com· 2 hours agoMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) recently announced the publication of the Phase 3...
AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF MYHIBBIN™ (mycophenolate mofetil oral...
FOX21 Colorado Springs· 23 hours agoAzurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the ...
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 3 hours agoTuesday, Mizuho adjusted its outlook on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), slashing the...
Summit Global Investments Purchases Shares of 587 West Pharmaceutical Services, Inc. (NYSE:WST)
ETF DAILY NEWS· 7 hours agoSummit Global Investments purchased a new position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) during the 4th quarter, according to the company ...
Q1 2024 Corvus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 hours agoFirst, this is a first-in-class drug with a novel mechanism of action. Soquelitinib index upstream by blocking Th 2 and Th 17 cells and thereby results...Area and Severity ...
‘I wonder if he’s on commission’: A psychiatrist online prescribed me Prozac, punched the air in...
MarketWatch via Yahoo Finance· 38 minutes ago“I processed a $50 copay, and attended my appointment with the psychiatrist. It went fast, and every...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus ...
FOX 23 News Albany· 14 hours agoPomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN). Such investors ...
